LGND logo

LGND Return On Equity

Annual ROE:

-0.53%-8.82%(-106.39%)
December 31, 2024

Summary

  • As of today, LGND annual return on equity is -0.53%, with the most recent change of -8.82% (-106.39%) on December 31, 2024.
  • During the last 3 years, LGND annual ROE has fallen by -10.51% (-105.31%).
  • LGND annual ROE is now -100.18% below its all-time high of 291.99%, reached on December 31, 1999.

Performance

LGND ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDprofitability metrics

Quarterly ROE:

-9.32%+7.06%(+43.10%)
June 30, 2025

Summary

  • As of today, LGND quarterly return on equity is -9.32%, with the most recent change of +7.06% (+43.10%) on June 30, 2025.
  • Over the past year, LGND quarterly ROE has dropped by -15.15% (-259.86%).
  • LGND quarterly ROE is now -100.49% below its all-time high of 1903.36%, reached on September 30, 2009.

Performance

LGND Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

LGND ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-106.4%-259.9%
3Y3 Years-105.3%-833.9%
5Y5 Years-100.6%-203.6%

LGND ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-105.3%+28.4%-167.4%+43.1%
5Y5-Year-100.6%+28.4%-167.4%+43.1%
All-TimeAll-Time-100.2%+100.0%-100.5%+99.7%

LGND ROE History

DateAnnualQuarterly
Jun 2025
-
-9.32%(+43.1%)
Mar 2025
-
-16.38%(-3111.8%)
Dec 2024
-0.53%(-106.4%)
-0.51%(-108.5%)
Sep 2024
-
5.97%(+2.4%)
Jun 2024
-
5.83%(-57.8%)
Mar 2024
-
13.82%(+68.3%)
Dec 2023
8.29%(+1220.3%)
8.21%(+164.0%)
Sep 2023
-
3.11%(-46.5%)
Jun 2023
-
5.81%(-17.2%)
Mar 2023
-
7.02%(+1132.4%)
Dec 2022
-0.74%(-107.4%)
-0.68%(-189.5%)
Sep 2022
-
0.76%(-40.2%)
Jun 2022
-
1.27%(-64.5%)
Mar 2022
-
3.58%(-53.3%)
Dec 2021
9.98%(+2595.0%)
7.66%(-15.8%)
Sep 2021
-
9.10%(+38.1%)
Jun 2021
-
6.59%(+17.9%)
Mar 2021
-
5.59%(+1431.0%)
Dec 2020
-0.40%(-100.4%)
-0.42%(+80.8%)
Sep 2020
-
-2.19%(+28.7%)
Jun 2020
-
-3.07%(+55.8%)
Mar 2020
-
-6.95%(-109.5%)
Dec 2019
94.76%(+217.6%)
73.17%(+4.2%)
Sep 2019
-
70.19%(-17.0%)
Jun 2019
-
84.56%(-23.9%)
Mar 2019
-
111.06%(+328.0%)
Dec 2018
29.84%(+780.2%)
25.95%(-24.4%)
Sep 2018
-
34.34%(+31.2%)
Jun 2018
-
26.18%(+102.6%)
Mar 2018
-
12.92%(+291.5%)
Dec 2017
3.39%(+513.4%)
3.30%(-26.2%)
Sep 2017
-
4.47%(+73.9%)
Jun 2017
-
2.57%(+382.4%)
Mar 2017
-
-0.91%(-24.7%)
Dec 2016
-0.82%(-100.5%)
-0.73%(-132.2%)
Sep 2016
-
2.27%(-97.1%)
Jun 2016
-
79.36%(-32.3%)
Mar 2016
-
117.23%(-32.4%)
Dec 2015
173.83%(+490.7%)
173.54%(-29.8%)
Sep 2015
-
247.21%(+289.1%)
Jun 2015
-
63.54%(+232.1%)
Mar 2015
-
19.13%(-14.0%)
Dec 2014
29.43%(+26.8%)
22.24%(+95.6%)
Sep 2014
-
11.37%(-17.5%)
Jun 2014
-
13.79%(-34.3%)
Mar 2014
-
20.99%(-9.3%)
Dec 2013
23.21%(+286.7%)
23.15%(-21.3%)
Sep 2013
-
29.40%(+8.2%)
Jun 2013
-
27.16%(+1808.2%)
Mar 2013
-
-1.59%(+85.0%)
Dec 2012
-12.43%(-112.8%)
-10.60%(-643.6%)
Sep 2012
-
1.95%(+107.2%)
Jun 2012
-
-26.96%(-540.4%)
Mar 2012
-
-4.21%(-104.1%)
Dec 2011
97.00%(+159.1%)
103.64%(-33.0%)
Sep 2011
-
154.70%(+623.9%)
Jun 2011
-
21.37%(-32.9%)
Mar 2011
-
31.83%(+116.6%)
Dec 2010
-164.10%(-38.5%)
-192.02%(+37.3%)
Sep 2010
-
-306.39%(-941.8%)
Jun 2010
-
-29.41%(+92.6%)
Mar 2010
-
-394.82%(-136.8%)
Dec 2009
-118.52%
1073.92%(-43.6%)
Sep 2009
-
1903.36%(+216.6%)
DateAnnualQuarterly
Jun 2009
-
-1632.89%(-139.5%)
Mar 2009
-
-681.87%(-41.7%)
Dec 2008
-448.71%(-423.8%)
-481.07%(-397.7%)
Sep 2008
-
-96.65%(-42.4%)
Jun 2008
-
-67.89%(-8.7%)
Mar 2008
-
-62.43%(+24.1%)
Dec 2007
-85.66%(+75.0%)
-82.20%(-434.7%)
Sep 2007
-
24.56%(+6722.2%)
Jun 2007
-
0.36%(-96.0%)
Mar 2007
-
9.09%(-89.0%)
Dec 2006
-342.24%(-1022.2%)
82.32%(-8.5%)
Sep 2006
-
89.94%(-13.3%)
Jun 2006
-
103.74%(-17.6%)
Mar 2006
-
125.97%(+227.2%)
Dec 2005
37.11%(+103.2%)
38.50%(+102.0%)
Sep 2005
-
19.06%(-65.6%)
Jun 2005
-
55.45%(-77.4%)
Mar 2005
-
245.41%(+257.4%)
Dec 2004
-1164.03%(-2276.1%)
-155.94%(-61.7%)
Sep 2004
-
-96.46%(-10.0%)
Jun 2004
-
-87.66%(-22.5%)
Mar 2004
-
-71.58%(-10.0%)
Dec 2003
-48.99%(+87.9%)
-65.08%(+26.7%)
Sep 2003
-
-88.77%(-18.2%)
Jun 2003
-
-75.12%(-0.7%)
Mar 2003
-
-74.57%(+1.7%)
Dec 2002
-403.92%(-643.7%)
-75.86%(+65.4%)
Sep 2002
-
-219.53%(+88.9%)
Jun 2002
-
-1984.72%(-1728.2%)
Mar 2002
-
121.90%(+37.4%)
Dec 2001
74.29%(-30.9%)
88.69%(-0.6%)
Sep 2001
-
89.23%(-24.2%)
Jun 2001
-
117.71%(-25.7%)
Mar 2001
-
158.49%(-22.9%)
Dec 2000
107.53%(-63.2%)
205.52%(-36.6%)
Sep 2000
-
324.20%(+11.7%)
Jun 2000
-
290.24%(+9.6%)
Mar 2000
-
264.74%(+3.3%)
Dec 1999
291.99%(+128.5%)
256.30%(-29.1%)
Sep 1999
-
361.45%(-62.4%)
Jun 1999
-
962.14%(+127.1%)
Mar 1999
-
-3554.65%(-144.9%)
Dec 1998
-1025.68%(-264.9%)
-1451.55%(-88.2%)
Sep 1998
-
-771.23%(-53.4%)
Jun 1998
-
-502.73%(-24.7%)
Mar 1998
-
-403.11%(-12.8%)
Dec 1997
-281.07%(-161.8%)
-357.35%(-86.2%)
Sep 1997
-
-191.87%(-4.7%)
Jun 1997
-
-183.33%(-0.2%)
Mar 1997
-
-183.02%(-4.0%)
Dec 1996
-107.36%(+50.7%)
-175.94%(-8.2%)
Sep 1996
-
-162.67%(-16.6%)
Jun 1996
-
-139.57%(+42.3%)
Mar 1996
-
-241.88%(-9.9%)
Dec 1995
-217.79%(-178.5%)
-220.01%(-3.3%)
Sep 1995
-
-212.92%(-0.5%)
Jun 1995
-
-211.87%(-143.6%)
Mar 1995
-
-86.96%(+1.0%)
Dec 1994
-78.19%(-101.3%)
-87.84%(-38.0%)
Sep 1994
-
-63.65%(-43.3%)
Jun 1994
-
-44.41%(-131.1%)
Mar 1994
-
-19.22%
Dec 1993
-38.85%(-58.8%)
-
Dec 1992
-24.47%
-

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual return on equity?
  • What is the all-time high annual ROE for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual ROE year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly return on equity?
  • What is the all-time high quarterly ROE for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly ROE year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual return on equity?

The current annual ROE of LGND is -0.53%

What is the all-time high annual ROE for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual return on equity is 291.99%

What is Ligand Pharmaceuticals Incorporated annual ROE year-on-year change?

Over the past year, LGND annual return on equity has changed by -8.82% (-106.39%)

What is Ligand Pharmaceuticals Incorporated quarterly return on equity?

The current quarterly ROE of LGND is -9.32%

What is the all-time high quarterly ROE for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly return on equity is 1903.36%

What is Ligand Pharmaceuticals Incorporated quarterly ROE year-on-year change?

Over the past year, LGND quarterly return on equity has changed by -15.15% (-259.86%)
On this page